The company confirmed it will participate in a one-on-one meeting with ADD Capital. The meeting is scheduled for Thursday, 17th September 2026 and will be conducted via Virtual Meeting mode.
The disclosure includes a note that the schedule may undergo changes on the part of the Analyst, Institutional Investor, or the Company. The company explicitly states that no unpublished price sensitive information pertaining to the Company is disclosed or shared at any of its meeting(s) with analysts/institutional investors.
A copy of the latest Investor Presentation is available on the Company's website at www.mukkaproteins.com.